Quest Diagnostics (DGX) delivered earnings and revenue surprises of 0.47% and 1.80%, respectively, for the quarter ended December 2023. Do…
Quest Diagnostics (DGX) subsidiary Haystack Oncology collaborates with TriSalus Life Sciences to improve therapeutic options for aggressive forms of cancer.…
Quest Diagnostics (DGX) partners with Fitbit to study the potential of wearable devices to improve metabolic health.…
Prestige Consumer Health (PBH), Quest Diagnostics (DGX) and Hologic (HOLX) are currently at discounted zone that are expected to provide…
Quest Diagnostics (DGX) fourth-quarter 2023 results are likely to reflect the robust strength of its base business.…
Quest Diagnostics (DGX) new partnership is likely to leverage its oncology expertise and national scale.…
Quest Diagnostics (DGX) recent acquisition seeks to increase accessibility to cutting-edge, high-caliber and reasonably priced laboratory services.…
Investors are optimistic about Quest Diagnostics (DGX) on strength in base business and strategic collaborations.…
Quest Diagnostics (DGX) launches the new 88-Compound NPS test panel to address the changing drug epidemic.…
Quest Diagnostics (DGX) wholly owned subsidiary, Haystack Oncology, partners with the Rutgers Cancer Institute of New Jersey.…
Quest Diagnostics (DGX) and CDC expand research collaboration to better understand the Hepatitis C burden in the United States.…
Investors are optimistic about Quest Diagnostics (DGX) on the strength of the base business.…
Quest Diagnostics (DGX) will supply next-generation sequencing and enhanced RNA extraction services for Sciphers PrismRA test through a new collaboration.…
Quest Diagnostics (DGX) latest partnership will increase the likelihood that Americans will eventually have an easy, reliable and accessible way…
Der amerikanische Medizintechniker Quest Diagnostics Inc. (ISIN: US74834L1008, NYSE: DGX) zahlt am 31. Januar 2024 eine vierteljährliche Dividende in Höhe…
Quest Diagnostics (DGX) can offer patients and physicians a seamless connection to Quest Diagnostics laboratory testing with the launch of…
…
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Asia Cervical Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends,…
Anzeige / WerbungQuest Diagnostics setzt Maßstäbe im bärischen BörsenumfeldWährend die Aktienmärkte aktuell allgemein auf Tauchstation gehen und ihrem Bärenmarkt folgen,…
…
…
Quest Diagnostics Inc. DGX said Tuesday its third-quarter profit dropped by 12.2% to $225 million, or $1.96 a share, from…
Quest Diagnostics (DGX) base business growth reflects the companys ongoing efforts to partner with health plans, hospitals and physicians amid…
Quest Diagnostics (DGX) third-quarter 2023 results are likely to reflect continued strength in the base business.…
Quest Diagnostics (DGX) recent acquisition of New York-Presbyterians outreach assets adds to volume growth within Physician Lab Services.…
Quest Diagnostics (DGX) continues to witness growth momentum in the cardiometabolic, endocrinology, infectious disease and carrier and prenatal genetic screening…
SECAUCUS, N.J., Aug. 14, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the worlds leading provider of diagnostic information services, today…
Investors are optimistic about Quest Diagnostics (DGX) on the strength of the base business performance and acquisitions....…
Quest Diagnostics Unveils Consumer-Initiated Alzheimer's Test >DGX...…
Quest Diagnostics Inc. DGX said Monday it has brought the first blood-based biomarker test to assess the risk of developing…
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
Quest Diagnostics (DGX) delivers better-than-expected earnings and revenues in the second quarter of 2023....…
Quest Diagnostics (DGX) delivered earnings and revenue surprises of 3.14% and 4.22%, respectively, for the quarter ended June 2023. Do…
...July 26 (Reuters) - Laboratory operator Quest
Diagnostics Inc beat......…
WASHINGTON (dpa-AFX) - Quest Diagnostics (DGX) released a profit for its second quarter that increased from the same period last…
Quest Diagnostics Cuts Profit Outlook Amid Higher Labor Costs...…
Quest Diagnostics 2Q Revenue Falls on Lower Productivity Effects...…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Second quarter revenues of $2.34 billion, down 4.7% from 2022 Second quarter reported diluted earnings per share ("EPS") of $2.05,…
NORTHAMPTON, MA / ACCESSWIRE / July 20, 2023 / Quest Diagnostics, through the Quest for Health Equity (Q4HE) initiative, has…
Investors are optimistic about Quest Diagnostics (DGX) on stronger base volume recovery and growth from strategic acquisitions....…
Quest Diagnostics (DGX) collaborates with Envision Sciences to bring a novel prosate cancer biomarker test....…
NORTHAMPTON, MA / ACCESSWIRE / July 13, 2023 / On May 23, several Quest Diagnostics employees volunteered at the Healthy…
Das Instrument QDI US74834L1008 QUEST DIAGNOSTICS DL-,01 EQUITY wird ex Dividende/Zinsen gehandelt am 10.07.2023
The instrument QDI US74834L1008 QUEST DIAGNOSTICS…
Quest Diagnostics (DGX) is dedicated to create cutting-edge laboratory tests to help assess patient risk for dementia and other degenerative…
NORTHAMPTON, MA / ACCESSWIRE / June 27, 2023 / Quest DiagnosticsQuest proudly fosters an inclusive workplace where all of our…
WASHINGTON (dpa-AFX) - Quest Diagnostics Inc. (DGX), the nations leading provider of diagnostic information services, on Wednesday announced that it…
WASHINGTON (dpa-AFX) - Quest Diagnostics Inc. (DGX), a US-based diagnostic laboratory, on Wednesday announced its agreement to acquire Haystack Oncology…
SECAUCUS, N.J., June 21, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the worlds leading provider of diagnostic information services,…
SECAUCUS, N.J., June 21, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), the nations leading provider of diagnostic information services, today announced…